AM

Amit Mittal

Director Director DIN 06570130
DIN 06570130 First appointment Jun 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2013
Shareholding value •••• Premium profile

About Amit Mittal

Data last updated:

Amit Mittal was a Director at Be Pellets Limited (2016–2020) and Director at Signa Medi Solutions Private Limited (2013–2020). The companies operate in Pharma.

DIN 06570130
Primary Designation Director
Industry Pharma
First Appointment 28 Jun 2013

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Be Pellets Limited U24232CH2016PLC035921
Director29 Jan 20162016₹2,724 (FY 2025)Active
Signa Medi Solutions Private Limited U24100CH2013PTC034576
Director28 Jun 20132013₹35.83 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Be Pellets Limited
Signa Medi Solutions Private Limited
Premium access

Shareholding and investment profile for Amit Mittal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amit Mittal

Amit Mittal was first appointed on 28 Jun 2013 as Director at Signa Medi Solutions Private Limited. The most recent appointment on record is 29 Jan 2016 at Be Pellets Limited.

Amit Mittal held 2 earlier board appointments: Be Pellets Limited (Director, 29 Jan 2016 to 15 Jul 2020); Signa Medi Solutions Private Limited (Director, 28 Jun 2013 to 15 Jul 2020).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available